Radiation doses to children during modified barium swallow studies

被引:46
作者
Weir, Kelly A.
McMahon, Sandra M.
Long, Gillian
Bunch, Judith A.
Pandeya, Nirmala
Coakley, Kerry S.
Chang, Anne B.
机构
[1] Univ Queensland, Royal Childrens Hosp, Sch Med, Discipline Paediat & Child Hlth, Herston, Qld 4029, Australia
[2] Speechnet Speech Pathol Serv, Brisbane, Qld, Australia
[3] Royal Childrens Hosp, Dept Med Imaging, Herston, Qld, Australia
[4] Queensland Inst Med Res, Herston, Qld 4006, Australia
[5] Royal Brisbane & Womens Hosp, Biomed Technol Serv, Herston, Qld, Australia
[6] Royal Childrens Hosp, Dept Resp Med, Herston, Qld, Australia
关键词
modified barium swallow; videofluoroscopic swallow study; pediatric dosimetry; effective dose;
D O I
10.1007/s00247-006-0397-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background There are minimal data on radiation doses to infants and children undergoing a modified barium swallow (MBS) study. Objective To document screening times, dose area product (DAP) and effective doses to children undergoing MBS and to determine factors associated with increased screening times and effective dose. Materials and methods Fluoroscopic data ( screening time, DAP, kVp) for 90 consecutive MBS studies using pulse fluoroscopy were prospectively recorded; effective dose was calculated and data were analyzed for effects of behavior, number of swallow presentations, swallowing dysfunction and medical problems. Results Mean effective dose for the entire group was 0.0826 +/- 0.0544 mSv, screening time 2.48 +/- 0.81 min, and DAP 28.79 +/- 41.72 cGy cm(2). Significant differences were found across three age groups (<= 1.0, > 1.0 - 3.0 and > 3.0 years) for effective dose ( mean 0.1188, 0.0651 and 0.0529 mSv, respectively; P < 0.001), but not for screening time or DAP. Effective dose was correlated with screening time ( P= 0.007), DAP ( P< 0.001), number of swallow presentations ( P= 0.007), lower age ( P= 0.017), female gender ( P= 0.004), and height ( P< 0.001). Screening time was correlated with total number of swallow presentations ( P< 0.001) and DAP ( P< 0.001). Conclusion Screening times, DAP, effective dose, and child and procedural factors associated with higher effective doses are presented for children undergoing MBS studies.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 26 条
[1]  
Arvedson J.C., 1998, PEDIAT VIDEOFLUOROSC
[2]  
*AUSTR RAD PROT NU, 2002, RAD PROT SER, V1
[3]   Agreement of aspiration tests using barium videofluoroscopy, salivagram, and milk scan in children with cerebral palsy [J].
Baikie, G ;
South, MJ ;
Reddihough, DS ;
Cook, DJ ;
Cameron, DJS ;
Olinsky, A ;
Ferguson, E .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2005, 47 (02) :86-93
[4]  
Benson J, 1994, DISORDERS FEEDING SW, P187
[5]   Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative [J].
Brenner, DJ .
PEDIATRIC RADIOLOGY, 2002, 32 (04) :228-231
[6]   Effective dose in paediatric computed tomography [J].
Chapple, CL ;
Willis, S ;
Frame, J .
PHYSICS IN MEDICINE AND BIOLOGY, 2002, 47 (01) :107-115
[7]   Normalized dose data for upper gastrointestinal tract contrast studies performed to infants [J].
Damilakis, J ;
Stratakis, J ;
Raissaki, M ;
Perisinakis, K ;
Kourbetis, N ;
Gourtsoyiannis, N .
MEDICAL PHYSICS, 2006, 33 (04) :1033-1040
[8]   Correlates of specific childhood feeding problems [J].
Field, D ;
Garland, M ;
Williams, K .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2003, 39 (04) :299-304
[9]  
GRIGGS CA, 1989, DEV MED CHILD NEUROL, V31, P303
[10]   Effective doses to adult and pediatric patients [J].
Huda, W .
PEDIATRIC RADIOLOGY, 2002, 32 (04) :272-279